The addition of bevacizumab (BVZ) to the standard regimen for the treatment of advanced colorectal cancer (CRC) appears to increase the risk of cardiovascular events, suggest the results of a meta-analysis presented at the recent ASCO Gastrointestinal Cancers Symposium (ASCO GI 2023).
Treatment with single fraction radiation therapy (RT) results in lesser hepatic pain in most patients with end-stage hepatocellular carcinoma (HCC) or liver metastases, according to a study presented at the recent ASCO Gastrointestinal Cancers Symposium (ASCO GI 2023).
The Ask the Experts: A discussion on patient navigation and choice of therapy webinar on 26 November 2022 highlighted to participants of the COREC Initiative: Battling colorectal cancer together the importance of patient navigation in overcoming challenges and barriers in colorectal cancer (CRC) care and management and improving patient outcomes.
New drug applications approved by US FDA as of 16-31 January 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Eating almonds provides no prebiotic effect on foecal bifidobacteria abundance and does not induce major changes in other gastrointestinal (GI) microbiota, GI transit, pH, pressure, stool output, or gut symptoms in adults, a study has shown.
Academic stress may take a toll on the mental health status of university students, particularly during examination periods, but walnut consumption may help thwart such negative effects, a study from Australia has shown.
Adopting a low-microbial, protective (neutropenic) diet offers no clear benefit to patients following hematopoietic stem cell transplantation (HSCT) in a study described as the first to investigate the role of neutropenic diet post-HSCT.
Nonalcoholic fatty liver disease (NAFLD) screening strategies, particularly vibration-controlled transient elastography (VCTE) and fibrosis-4 (FIB-4), are a cost-effective approach to reduce disease burden among type 2 diabetes mellitus (T2DM) patients in Singapore, according to a study.